Natera’s Therapeutics & Innovations group is at the forefront of applying AI, genomics, and multimodal data to transform precision medicine. From building genomic foundation models to developing predictive AI platforms, our mission is to accelerate biomarker discovery, improve clinical trial design, and enable novel personalized therapeutics.